• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗菌药物管理:对抗抗菌药物耐药性并保护全球公共卫生。

Antimicrobial Stewardship: Fighting Antimicrobial Resistance and Protecting Global Public Health.

作者信息

Majumder Md Anwarul Azim, Rahman Sayeeda, Cohall Damian, Bharatha Ambadasu, Singh Keerti, Haque Mainul, Gittens-St Hilaire Marquita

机构信息

Faculty of Medical Sciences, The University of the West Indies, Cave Hill Campus, Bridgetown, Barbados.

School of Medicine, American University of Integrative Sciences, Bridgetown, Barbados.

出版信息

Infect Drug Resist. 2020 Dec 29;13:4713-4738. doi: 10.2147/IDR.S290835. eCollection 2020.

DOI:10.2147/IDR.S290835
PMID:33402841
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7778387/
Abstract

Antimicrobial resistance (AMR) is a serious threat to global public health. It increases morbidity and mortality, and is associated with high economic costs due to its health care burden. Infections with multidrug-resistant (MDR) bacteria also have substantial implications on clinical and economic outcomes. Moreover, increased indiscriminate use of antibiotics during the COVID-19 pandemic will heighten bacterial resistance and ultimately lead to more deaths. This review highlights AMR's scale and consequences, the importance, and implications of an antimicrobial stewardship program (ASP) to fight resistance and protect global health. Antimicrobial stewardship (AMS), an organizational or system-wide health-care strategy, is designed to promote, improve, monitor, and evaluate the rational use of antimicrobials to preserve their future effectiveness, along with the promotion and protection of public health. ASP has been very successful in promoting antimicrobials' appropriate use by implementing evidence-based interventions. The "One Health" approach, a holistic and multisectoral approach, is also needed to address AMR's rising threat. AMS practices, principles, and interventions are critical steps towards containing and mitigating AMR. Evidence-based policies must guide the "One Health" approach, vaccination protocols, health professionals' education, and the public's awareness about AMR.

摘要

抗菌药物耐药性(AMR)是对全球公共卫生的严重威胁。它会增加发病率和死亡率,并且由于其医疗负担而带来高昂的经济成本。多重耐药(MDR)细菌感染也对临床和经济结果有重大影响。此外,在新冠疫情期间抗生素的过度使用将加剧细菌耐药性,最终导致更多死亡。本综述强调了AMR的规模和后果、抗菌药物管理计划(ASP)对抗击耐药性和保护全球健康的重要性及影响。抗菌药物管理(AMS)是一种组织或全系统范围的医疗保健策略,旨在促进、改善、监测和评估抗菌药物的合理使用,以保持其未来的有效性,同时促进和保护公众健康。ASP通过实施循证干预措施,在促进抗菌药物的合理使用方面非常成功。应对AMR日益严重的威胁还需要“同一健康”方法,这是一种全面的多部门方法。AMS的实践、原则和干预措施是遏制和缓解AMR的关键步骤。循证政策必须指导“同一健康”方法、疫苗接种方案、卫生专业人员教育以及公众对AMR的认识。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f7a1/7778387/ade9edbca2c7/IDR-13-4713-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f7a1/7778387/ade9edbca2c7/IDR-13-4713-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f7a1/7778387/ade9edbca2c7/IDR-13-4713-g0001.jpg

相似文献

1
Antimicrobial Stewardship: Fighting Antimicrobial Resistance and Protecting Global Public Health.抗菌药物管理:对抗抗菌药物耐药性并保护全球公共卫生。
Infect Drug Resist. 2020 Dec 29;13:4713-4738. doi: 10.2147/IDR.S290835. eCollection 2020.
2
Opportunities to Enhance Diagnostic Testing and Antimicrobial Stewardship: A Qualitative Multinational Survey of Healthcare Professionals.加强诊断检测和抗菌药物管理的机遇:一项针对医疗保健专业人员的定性多国调查
Infect Dis Ther. 2024 Jul;13(7):1621-1637. doi: 10.1007/s40121-024-00996-1. Epub 2024 Jun 3.
3
An Overview of Preventive Strategies and the Role of Various Organizations in Combating Antimicrobial Resistance.预防策略概述及各组织在抗击抗菌药物耐药性中的作用
Cureus. 2023 Sep 4;15(9):e44666. doi: 10.7759/cureus.44666. eCollection 2023 Sep.
4
AMR and Sustainable Development Goals: at a crossroads.抗微生物药物耐药性和可持续发展目标:处在十字路口。
Global Health. 2024 Oct 17;20(1):73. doi: 10.1186/s12992-024-01046-8.
5
An Overview of the Recent Advances in Antimicrobial Resistance.抗菌药物耐药性的最新进展概述
Microorganisms. 2024 Sep 21;12(9):1920. doi: 10.3390/microorganisms12091920.
6
Antimicrobial Stewardship抗菌药物管理
7
The Impact of Vaccination as a Strategy to Combat Bacterial Antimicrobial Resistance.疫苗接种作为对抗细菌抗微生物药物耐药性策略的影响
Cureus. 2024 Jul 31;16(7):e65840. doi: 10.7759/cureus.65840. eCollection 2024 Jul.
8
Building an antimicrobial stewardship model for a public-sector hospital: a pre-implementation study.构建公立医疗机构抗菌药物管理模式:一项实施前研究。
J Med Microbiol. 2024 Jul;73(7). doi: 10.1099/jmm.0.001853.
9
An Assessment of the Current Level of Implementation of the Core Elements of Antimicrobial Stewardship Programs in Public Hospitals in Ghana.加纳公立医院抗菌药物管理计划核心要素的当前实施水平评估
Hosp Pharm. 2024 Jun;59(3):367-377. doi: 10.1177/00185787231224066. Epub 2024 Feb 15.
10
Effectiveness of interventions to improve the public's antimicrobial resistance awareness and behaviours associated with prudent use of antimicrobials: a systematic review.干预措施提高公众对抗微生物药物合理使用相关的抗生素耐药性认识和行为的有效性:系统评价。
J Antimicrob Chemother. 2018 Jun 1;73(6):1464-1478. doi: 10.1093/jac/dky076.

引用本文的文献

1
Evaluation of current practice of antimicrobial use and clinical outcome in the management of pneumonia among pediatric patients admitted to Jimma Medical Center, Southwest Ethiopia: a prospective observational study.埃塞俄比亚西南部吉马医疗中心收治的小儿肺炎患者抗菌药物使用现状及临床结局评估:一项前瞻性观察研究
Ann Med Surg (Lond). 2025 Aug 5;87(9):5470-5481. doi: 10.1097/MS9.0000000000003690. eCollection 2025 Sep.
2
Exploring the potential of photodynamic therapy in overcoming multidrug resistance: mechanisms, synergies, and clinical advancements in infectious diseases.探索光动力疗法在克服多重耐药性方面的潜力:机制、协同作用及传染病领域的临床进展
Front Cell Infect Microbiol. 2025 Aug 14;15:1624036. doi: 10.3389/fcimb.2025.1624036. eCollection 2025.
3

本文引用的文献

1
Microbial Resistance Movements: An Overview of Global Public Health Threats Posed by Antimicrobial Resistance, and How Best to Counter.微生物耐药动态:对抗菌药物耐药性所构成的全球公共卫生威胁的概述以及最佳应对方法。
Front Public Health. 2020 Nov 4;8:535668. doi: 10.3389/fpubh.2020.535668. eCollection 2020.
2
Strategies to Prevent Healthcare-Associated Infections: A Narrative Overview.预防医疗相关感染的策略:叙述性概述
Risk Manag Healthc Policy. 2020 Sep 28;13:1765-1780. doi: 10.2147/RMHP.S269315. eCollection 2020.
3
Antimicrobial stewardship in hospitals in Latin America and the Caribbean: a scoping review.
An antibiotic stewardship initiative focused on community-acquired bacterial pneumonia (CABP) in outpatient clinics and urgent care centers: a 2023-2024 community health system experience.一项针对门诊诊所和紧急护理中心社区获得性细菌性肺炎(CABP)的抗生素管理倡议:2023 - 2024年社区卫生系统经验
Antimicrob Steward Healthc Epidemiol. 2025 Aug 15;5(1):e185. doi: 10.1017/ash.2025.10100. eCollection 2025.
4
N-doped TiO/prosopis juliflora biochar nanocomposites for removal of ciprofloxacin from pharmaceutical industrial wastewater.用于去除制药工业废水中环丙沙星的氮掺杂二氧化钛/牧豆树生物炭纳米复合材料
Sci Rep. 2025 Aug 29;15(1):31795. doi: 10.1038/s41598-025-03330-y.
5
Nanopore Sequencing-Driven Mapping of Antimicrobial Resistance Genes in Selected Isolates from Pigs and Poultry Layers in Nigeria.纳米孔测序驱动的尼日利亚猪和蛋鸡选定分离株中抗菌药物耐药基因的定位
Antibiotics (Basel). 2025 Aug 14;14(8):827. doi: 10.3390/antibiotics14080827.
6
Heterologous Expression and Antimicrobial Targets of a Novel Glycine-Rich Antimicrobial Peptide from .来自……的一种新型富含甘氨酸抗菌肽的异源表达及抗菌靶点
Mar Drugs. 2025 Aug 17;23(8):330. doi: 10.3390/md23080330.
7
Impact of Antibiotic Stewardship on the Management of Pelvic Inflammatory Disease: A Multicenter Gynecological and Public Health Perspective in Pakistan.抗生素管理对盆腔炎治疗的影响:巴基斯坦多中心妇科与公共卫生视角
Cureus. 2025 Jul 25;17(7):e88739. doi: 10.7759/cureus.88739. eCollection 2025 Jul.
8
Exploring the antibacterial potential of environmental Pseudomonas aeruginosa isolates: Insights from in vitro studies and genome mining approaches.探索环境中分离出的铜绿假单胞菌的抗菌潜力:来自体外研究和基因组挖掘方法的见解。
J Genet Eng Biotechnol. 2025 Sep;23(3):100508. doi: 10.1016/j.jgeb.2025.100508. Epub 2025 May 17.
9
Antimicrobial resistance to colistin in neonates: epidemiological insights and public health implications in Nigeria - a mini review.新生儿对黏菌素的耐药性:尼日利亚的流行病学见解及公共卫生影响——一篇综述
Ann Med. 2025 Dec;57(1):2536197. doi: 10.1080/07853890.2025.2536197. Epub 2025 Aug 22.
10
Systems Policy Analysis for Antimicrobial Resistance Targeted Action (SPAARTA): A Research Protocol.抗菌药物耐药性靶向行动的系统政策分析(SPAARTA):一项研究方案。
Wellcome Open Res. 2025 Jul 30;9:700. doi: 10.12688/wellcomeopenres.22923.2. eCollection 2024.
拉丁美洲和加勒比地区医院的抗菌药物管理:一项范围综述
Rev Panam Salud Publica. 2020 Sep 23;44:e68. doi: 10.26633/RPSP.2020.68. eCollection 2020.
4
CRISPR-Cas system: a potential alternative tool to cope antibiotic resistance.CRISPR-Cas 系统:应对抗生素耐药性的潜在替代工具。
Antimicrob Resist Infect Control. 2020 Aug 10;9(1):131. doi: 10.1186/s13756-020-00795-6.
5
Handwashing in averting infectious diseases: Relevance to COVID-19.洗手在预防传染病中的作用:与2019冠状病毒病的相关性
J Popul Ther Clin Pharmacol. 2020 Jul 12;27(S Pt 1):e37-e52. doi: 10.15586/jptcp.v27SP1.711.
6
Tackling antimicrobial resistance in the COVID-19 pandemic.应对新冠疫情中的抗菌药物耐药性问题。
Bull World Health Organ. 2020 Jul 1;98(7):442-442A. doi: 10.2471/BLT.20.268573.
7
Tackling Antimicrobial Resistance by promoting Antimicrobial stewardship in Medical and Allied Health Professional Curricula.通过在医学和相关健康专业课程中推广抗菌药物管理来应对抗菌药物耐药性。
Expert Rev Anti Infect Ther. 2020 Dec;18(12):1245-1258. doi: 10.1080/14787210.2020.1796638. Epub 2020 Aug 17.
8
Antimicrobial stewardship programs; a two-part narrative review of step-wise design and issues of controversy Part I: step-wise design of an antimicrobial stewardship program.抗菌药物管理计划;关于逐步设计及争议问题的两部分叙述性综述 第一部分:抗菌药物管理计划的逐步设计
Ther Adv Infect Dis. 2020 Jun 19;7:2049936120933187. doi: 10.1177/2049936120933187. eCollection 2020 Jan-Dec.
9
The Novel Coronavirus COVID-19 Outbreak: Global Implications for Antimicrobial Resistance.新型冠状病毒COVID-19疫情:对抗菌药物耐药性的全球影响
Front Microbiol. 2020 May 13;11:1020. doi: 10.3389/fmicb.2020.01020. eCollection 2020.
10
Impact of an antimicrobial stewardship program in the antimicrobial-resistant and prevalence of clostridioides difficile infection and amount of antimicrobial consumed in cancer patients.抗微生物药物管理计划对癌症患者的抗微生物药物耐药性和艰难梭菌感染患病率以及抗微生物药物消耗量的影响。
BMC Res Notes. 2020 May 19;13(1):246. doi: 10.1186/s13104-020-05085-3.